This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does Aster tataricus work to treat chronic cough?
Aster tataricus contains active compounds called astersaponins and shionone, which are believed to exert expectorant and antitussive effects. In Traditional Chinese Medicine, this herb works by moistening the lungs and directing lung qi downward, helping to resolve chronic cough patterns. Laboratory studies suggest aster saponins may reduce airway inflammation and promote mucus clearance, though human clinical trials remain limited. Evidence Level: C and Traditional use support these mechanisms.
Does Aster tataricus interact with any medications?
There are no well-documented drug interactions for Aster tataricus in current medical literature. However, due to limited research, caution is advised when combining with anticoagulant medications, as some saponin-containing herbs may affect blood clotting. Patients taking medications for asthma or chronic lung conditions should consult a healthcare provider before use, as therapeutic effects may be additive. Always inform your practitioner of all supplements you are taking. Evidence Level: C.
What is the recommended dosage for Aster tataricus root?
The typical adult dosage for Aster tataricus is 5-9 grams of dried root daily, usually prepared as a decoction. Standardized extracts are also available, with approximately 300mg daily being a common recommendation. Dosage may vary based on the specific formulation and condition being treated. This herb is typically combined with other herbs in Traditional Chinese Medicine formulas rather than used alone. Consult a qualified practitioner for personalized dosing. Evidence Level: Traditional.
Is Aster tataricus safe to take during pregnancy?
Aster tataricus is considered unsafe during pregnancy and should be avoided. Traditional Chinese Medicine sources contraindicate its use in pregnant women, though specific adverse effects have not been well-documented in clinical studies. Due to insufficient safety data and the presence of saponins, which may stimulate uterine activity, pregnant and breastfeeding women should not use this herb. Women planning pregnancy should also avoid this supplement. Evidence Level: C.
What conditions is Aster tataricus used to treat?
In Traditional Chinese Medicine, Aster tataricus (known as Zi Wan) is primarily used to treat chronic cough, asthma, and lung deficiency patterns. It is indicated for productive cough with difficult expectoration, hemoptysis, and bronchitis. The herb moistens the lungs and directs rebellious lung qi downward. It is specifically contraindicated in cases of lung heat with excess phlegm without underlying deficiency. Evidence Level: C and Traditional use.
What side effects can Aster tataricus cause?
Aster tataricus is generally well-tolerated at therapeutic doses. Reported side effects are primarily mild gastrointestinal upset, including nausea or stomach discomfort. These effects are typically dose-dependent and may resolve by taking the herb with food. No serious adverse events have been documented in traditional use. However, individuals with known allergies to plants in the Asteraceae family should exercise caution, as allergic reactions are possible. Evidence Level: C.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Aster tataricus is a perennial herb used in traditional East Asian medicine, primarily for respiratory conditions, and has demonstrated anti-inflammatory, antiviral, and bone-protective activities in preclinical studies [PMID:36080154, 40665421, 38003715].
Background
Aster tataricus L.f. is a perennial herb of the Asteraceae family, known in traditional Chinese medicine as 'Zi wan' or 'Fan huncao' [PMID:40271061, 39166058]. The medicinal parts include the flowers, leaves, roots, and rhizomes [PMID:40271061].
Traditional uses
It has been used for over 2000 years to treat cough, asthma, and inflammation, clear lung qi, promote fluid flow, resolve sputum, and regulate secretions [PMID:39166058, 40271061]. It is also traditionally used to moisten intestines and relieve constipation [PMID:33378996].
Active compounds
The herb contains a diverse array of bioactive compounds, including terpenoids, flavonoids (such as quercetin, kaempferol, and isorhamnetin), peptides, sterols, anthraquinones, phenylpropanoids, coumarins, and saponins [PMID:40520551, 36520245, 30931559]. Specific identified compounds include epifriedelinol, chlorogenic acid, and novel tatarisides A-E [PMID:33289282, 38296166, 41071724].
Mechanism of action
Anti-inflammatory effects are mediated through the inhibition of NF-κB activation, suppression of NO, iNOS, and COX-2 [PMID:31473471, 30931559]. Bone-protective effects involve the inhibition of RANKL-induced osteoclastogenesis and suppression of NFATc1 and c-Fos via MAPK signaling pathways [PMID:38003715, 41071724]. Antiviral activity is associated with the induction of type-I interferon (IFN) signaling and cytokine secretion [PMID:40665421].
Clinical evidence
Evidence DRespiratory conditions (Cough/Asthma)
Extracts demonstrated expectorant and antitussive activities in mouse models [PMID:25701752] and attenuated asthma by inhibiting tracheal ring contraction and inflammation [PMID:32784051].
Evidence DPulmonary Fibrosis
Self-assembled vectors derived from A. tataricus mitigated bleomycin-induced pulmonary fibrosis in mice [PMID:40520551].
Evidence DViral Infections
Extracts showed antiviral effects against Influenza A, Newcastle Disease Virus, and Herpes Simplex Virus-1 in vitro and in vivo [PMID:40665421].
Evidence DOsteoporosis
Ethanol extract and epifriedelinol suppressed osteoclast differentiation and protected against trabecular bone degradation in ovariectomized mice [PMID:38003715, 41071724].
Evidence DConstipation
Ethanol extract promoted small intestinal charcoal transit and decreased remnant fecal amount in loperamide-induced constipation mice [PMID:33378996].
Evidence D
Safety & adverse effects
A. tataricus is noted to have certain hepatotoxicity [PMID:40271061]. In an acute toxicity study in rats, the LD50 of a 75% alcohol extract was 15.74 g/kg body weight [PMID:28480359].
Evidence summary
The current evidence is based primarily on in vitro studies and animal models (Level D), demonstrating significant pharmacological potential in respiratory, inflammatory, and bone health, though human clinical trials are lacking.
PubMed sources
1.PMID: 40520551 (2025) — Self-assembled vectors derived from Aster tataricus L.f. mitigate bleomycin-induced pulmonary fibrosis in mice. · Materials today. Bio
2.PMID: 38296166 (2024) — Five new secondary metabolites from Aster tataricus. · Fitoterapia
3.PMID: 39166058 (2024) — An updated and comprehensive review of the morphology, ethnomedicinal uses, phytochemistry, and pharmacological activity of Aster tataricus L. f. · Heliyon
4.PMID: 40271061 (2025) — Aster tataricus L. f.: a review on the botany, phytochemistry, ethnopharmacology, pharmacology, toxicology and comprehensive utilization. · Frontiers in pharmacology
5.PMID: 40665421 (2025) — Aster tataricus extract and its active compounds display a broad spectrum of antiviral activity in vitro and in vivo.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
Extract significantly alleviated bladder wall inflammation and protected against NLRP3-mediated pyroptosis in rat and human cell models [PMID:33030301].
· Chinese medicine
6.PMID: 38081397 (2024) — Baiheqingjin formula reduces inflammation in mice with asthma by inhibiting the PI3K/AKT/NF-κb signaling pathway. · Journal of ethnopharmacology
7.PMID: 36080154 (2022) — Radix Asteris: Traditional Usage, Phytochemistry and Pharmacology of An Important Traditional Chinese Medicine. · Molecules (Basel, Switzerland)
8.PMID: 28480359 (2016) — EVALUATION OF THE ACUTE AND SUBCHRONIC TOXICITY OF Aster tataricus L. F. · African journal of traditional, complementary, and alternative medicines : AJTCAM
9.PMID: 31473471 (2019) — Identification of potential inflammatory inhibitors from Aster tataricus. · Bioorganic chemistry
10.PMID: 31909569 (2020) — Comparison of the active components of Aster tataricus from different regions and related processed products by ultra-high performance liquid chromatography with tandem mass spectrometry. · Journal of separation science
11.PMID: 36520245 (2023) — Metabolomics and transcriptomics provide insights into the flavonoid biosynthesis pathway in the roots of developing Aster tataricus. · Journal of plant research
12.PMID: 30248930 (2018) — Complete Chloroplast Genome Sequence and Phylogenetic Analysis of Aster tataricus. · Molecules (Basel, Switzerland)
13.PMID: 37673198 (2024) — Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid. · Journal of ethnopharmacology
14.PMID: 34405960 (2021) — Comparison of the chemical profile differences of Aster tataricus between raw and processed products by metabolomics coupled with chemometrics methods. · Journal of separation science
15.PMID: 25701752 (2015) — Expectorant, antitussive, anti-inflammatory activities and compositional analysis of Aster tataricus. · Journal of ethnopharmacology
16.PMID: 33615932 (2022) — A new biflavonoids from Aster tataricus induced non-apoptotic cell death in A549 cells. · Natural product research
17.PMID: 33378996 (2021) — Aster tataricus alleviates constipation by antagonizing the binding of acetylcholine to muscarinic receptor and inhibiting Ca2+ influx. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
18.PMID: 8588868 (1996) — New pentapeptides from Aster tataricus. · Phytochemistry
19.PMID: 7765211 (1994) — Oligopeptides from Aster tataricus. · Phytochemistry
20.PMID: 33030301 (2020) — Protective effect of Aster tataricus extract on NLRP3-mediated pyroptosis of bladder urothelial cells. · Journal of cellular and molecular medicine
21.PMID: 28920330 (2016) — [Oligopeptides in plant medicines cited in Chinese Pharmacopoeia]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
22.PMID: 32784051 (2020) — Aster tataricus attenuates asthma efficiently by simultaneously inhibiting tracheal ring contraction and inflammation. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
23.PMID: 41396826 (2025) — High-Performance Liquid Chromatography Fingerprint Combined with Chemical Pattern Recognition Method to Evaluate the Correlations and Differences between Aster tataricus L.f. Decoction and its Formula Granule. · Journal of chromatographic science
24.PMID: 33289282 (2021) — Pharmacokinetic comparison of 15 active compositions in rat plasma after oral administration of raw and honey-processed Aster tataricus extracts. · Journal of separation science
25.PMID: 36586529 (2023) — Neuropyrones A-E, five undescribed α-pyrone derivatives with tyrosinase inhibitory activity from the endophytic fungus Neurospora dictyophora WZ-497. · Phytochemistry
26.PMID: 39197804 (2025) — Mechanism of Jizhi syrup's prevention and treatment of acute bronchitis based on LPS-iNOS inflammatory mediators' signalling. · Journal of ethnopharmacology
27.PMID: 30931559 (2019) — Anti-inflammatory Potential of Saponins from Aster tataricus via NF-κB/MAPK Activation. · Journal of natural products
28.PMID: 38003715 (2023) — Ethanol Extract of Radix Asteris Suppresses Osteoclast Differentiation and Alleviates Osteoporosis. · International journal of molecular sciences
29.PMID: 30696024 (2019) — Network Pharmacology-Based Investigation of Protective Mechanism of Aster tataricus on Lipopolysaccharide-Induced Acute Lung Injury. · International journal of molecular sciences
30.PMID: 41071724 (2025) — Epifriedelinol From Aster tataricus Suppresses Osteoclast Differentiation and Bone Resorption via MAPK-Mediated Inhibition of NFATc1/c-Fos in RAW264.7 and BMM Cells: An In Vitro Study. · Chemistry & biodiversity